ABUS vs PGR · P/E 5.4, rev $6.2M vs P/E 10, rev $87.67B
Arbutus Biopharma Corp (ABUS) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the ABUS and PGR stock pages for the full models.
Not investment advice.